Mark A. Glickman - Co-Chief Executive Officer at TherapeuticsMD, Inc.

Issuer-level insider activity

Role
Co-Chief Executive Officer
Issuer ticker
TXMD on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mark A. Glickman since 28 Sep 2025

Reported holdings for Mark A. Glickman in TherapeuticsMD, Inc.

Form 4 holding Co-Chief Executive Officer

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
3,466
Estimated value
$12,610
Report date
06 Dec 2022
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-Chief Executive Officer

TherapeuticsMD, Inc.

Security class
Common Stock
Shares / value
1,294
Estimated value
$2,897
Report date
06 Dec 2022
Price
$2.24
Ownership
Direct

Transaction history for Mark A. Glickman in TherapeuticsMD, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .